Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

130.59 +1.33 (+1.03%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9

...

50 51 Next >

2 Sweet Dividend Stocks to Buy to Satisfy Your Craving for Passive Income ↗

November 15, 2025

Dividend stocks can strengthen your portfolio during any market environment.

Via The Motley Fool

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. ↗

November 15, 2025

These stocks pay income that investors can count on over the long run.

Via The Motley Fool

Topics Intellectual Property

Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty

November 14, 2025

As the broader market concluded with a mixed performance on November 14, 2025, the S&P 500 Healthcare sector once again underscored its often-defensive nature, demonstrating resilience amidst an...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

What Does the Market Think About Abbott Laboratories? ↗

November 14, 2025

Via Benzinga

Chicago Fed's 7th District Hiring Expectations Crash to -40: A Dire Signal for the Economy and Fed Policy

November 10, 2025

The economic outlook for the U.S. Midwest has taken a concerning turn as the Chicago Federal Reserve's 7th District hiring expectations index reportedly plummeted to -40 in October 2025. This alarming...

Via MarketMinute

Topics Artificial Intelligence Economy Immigration

2 Top Dividend Stocks to Buy and Hold Forever ↗

November 10, 2025

These companies have already handsomely rewarded longtime shareholders, and it's not too late to join the party.

Via The Motley Fool

Corporate Earnings Fuel Market Gains, But Mixed Results Hint at Underlying Volatility

November 07, 2025

Recent third-quarter (Q3) 2025 corporate earnings have painted a complex yet largely positive picture for North American equity markets. While robust performances from key sectors, particularly...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

Q3 Earnings Outperformers: Abbott Laboratories (NYSE:ABT) And The Rest Of The Medical Devices & Supplies - Diversified Stocks

November 03, 2025

Looking back on medical devices & supplies - diversified stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Abbott Laboratories (NYSE:ABT) and its peers.

Via StockStory

Economic Crossroads: How Key Indicators Are Steering the Stock Market Through Moderation and Policy Shifts

November 05, 2025

The financial markets are currently navigating a complex and often contradictory economic landscape, heavily influenced by a suite of critical indicators such as jobs data and the Purchasing Managers'...

Via MarketMinute

Topics Artificial Intelligence Economy Immigration

AI's Power Problem ↗

November 03, 2025

AIs are hungry and growing more insatiable by the day. Will we be able to sustainably generate the power needed to feed the AI beast?

Via The Motley Fool

Topics Artificial Intelligence Economy Energy

ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat ↗

November 01, 2025

Via MarketBeat

Dexcom Stock, Down 13%, Haunted By Its 'Surprisingly Cautious' Outlook ↗

October 31, 2025

Dexcom's solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook, and Dexcom stock tumbled.

Via Investor's Business Daily

Should You Buy DexCom Stock Before Oct. 31? ↗

October 30, 2025

The company hasn't had a great year. Is it about to turn things around?

Via The Motley Fool

Topics Lawsuit

Recent Corporate Earnings Fuel Market Rally to Record Highs: AI and Rate Cut Hopes Drive Optimism

October 28, 2025

The third-quarter (Q3) 2025 earnings season has delivered a powerful jolt to global financial markets, propelling major U.S. indices to unprecedented record highs. A wave of surprisingly robust...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Is the Market Bullish or Bearish on Abbott Laboratories? ↗

October 28, 2025

Via Benzinga

Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You? ↗

October 28, 2025

Englander seems to have had several good reasons to aggressively buy shares of this big drugmaker.

Via The Motley Fool

Topics Intellectual Property

Abbott Laboratories (NYSE:ABT): A Strong Dividend Stock for Reliable Income and Growth ↗

October 27, 2025

Discover Abbott Laboratories (ABT), a top dividend stock with a 1.87% yield, 11% growth, and a strong financial profile for reliable income.

Via Chartmill

Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence

October 23, 2025

New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares...

Via MarketMinute

Topics Earnings Supply Chain

EXCLUSIVE: Trinity Capital's New Loan Fuels Bobbie's Mission To Set New US Infant Nutrition Standards ↗

October 23, 2025

Trinity Capital Inc. announced a financing agreement with Bobbie, an organic infant nutrition company, to boost production capacity and ensure wider distribution of its products.

Via Benzinga

1 Safe-and-Steady Stock with Exciting Potential and 2 We Question

October 23, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

A Look Into Abbott Laboratories Inc's Price Over Earnings ↗

October 22, 2025

Via Benzinga

Boston Scientific Soars: Q3 2025 Earnings Beat Ignites Medical Device Market

October 22, 2025

Boston Scientific (NYSE: BSX) has delivered an exceptional third-quarter 2025 earnings report, significantly surpassing analyst expectations and reinforcing its position as a leading innovator in the...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

The 5 Most Interesting Analyst Questions From Abbott Laboratories’s Q3 Earnings Call

October 22, 2025

Abbott Laboratories’ third quarter results met Wall Street’s expectations for both revenue and non-GAAP profit, but the market reacted negatively, with shares declining over 4%. Management pointed to...

Via StockStory

Topics Earnings

U.S. Job Growth Stalls at 0.1%: Echoes of 2009 as Economy Navigates Fragile Labor Market

October 21, 2025

The U.S. economy is currently grappling with a significant deceleration in job growth, with proprietary data from investment giant Vanguard revealing a meager 0.1% growth rate for seven of the first...

Via MarketMinute

Topics Artificial Intelligence Economy Immigration

Abbott Laboratories' October Price Plunge Is a Signal to Buy ↗

October 17, 2025

Abbott Laboratories is on track to reach new highs, potentially by early 2026, opening the door for a 30% stock price increase in addition to the dividend.

Via MarketBeat

Earnings Season Fuels Market Optimism Amidst Economic Headwinds

October 16, 2025

As the Q3 2025 earnings season unfolds, corporate America is delivering a powerful narrative of resilience and growth, significantly influencing overall stock market movements. Despite a complex...

Via MarketMinute

Topics Artificial Intelligence Economy Workforce

Analyst See Noise In Q3 P&L, Affirms Abbott's Medtech Strength ↗

October 16, 2025

Abbott eyes 10% EPS growth in 2026 with CGM momentum, new nutrition contracts, and medical device launches driving global expansion.

Via Benzinga

These Analysts Revise Their Forecasts On Abbott Following Q3 Results ↗

October 16, 2025

Via Benzinga

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. ↗

October 16, 2025

Investors should be able to count on these stocks to deliver steady and growing income over the long term.

Via The Motley Fool

ABT Q3 Deep Dive: Q3 Results in Line with Expectations, Product Pipeline and Market Dynamics Shape Outlook

October 16, 2025

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 6.9% year on year to $11.37 billion. Its non-GAAP profit of $1.30...

Via StockStory

Topics World Trade

< Previous 1 2 3 4 5 6 7 8 9

...

50 51 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Abbott Laboratories (NY:ABT)

All News about Abbott Laboratories

Starting at $3.75/week.

Subscribe Today